This week's edition of Science has a special section on clinical trials, and how they're figuratively ill. "The clinical trial itself is facing an epidemic -- of rising costs and blurred objectives," says the opening article.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.